Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Biomaterials Science

Background:

• Human embryonic stem cells (hESCs) hold potential for regenerative medicine.
• Efficient osteoblastic differentiation of hESCs is crucial for bone tissue engineering.
• Existing methods for hESC osteogenesis require optimization for clinical applications.

Purpose of the Study:

• To develop an efficient method for osteoblastic differentiation of hESCs.
• To investigate the role of primary bone-derived cells (PBDs) in hESC osteogenesis.
• To characterize the differentiation process and markers of osteogenesis in cocultured hESCs.

Main Methods:

• Coculturing of human embryonic stem cell-derived embryoid bodies (hEBs) with mitomycin C-treated primary bone-derived cells (PBDs).
• Culture in DMEM/F12 medium with 5% knockout serum replacement.
• Assessment of osteoblastic differentiation using von Kossa and Alizarin S staining for mineralization, and RT-PCR for osteoblast-specific gene expression.

Main Results:

• Prominent mineralization and nodule-like structure formation observed within 14 days.
• Significant upregulation of osteoblast-specific markers: bone sialoprotein, alkaline phosphatase, osteocalcin, collagen 1, and core binding factor alpha1.
• Flow cytometry analysis confirmed expression of osteocalcin in over 19% of differentiated cells.

Conclusions:

• Primary bone-derived cells (PBDs) effectively induce osteoblastic differentiation of hESCs.
• PBDs release osteogenic factors, including bone morphogenic proteins (BMPs) 2 and 4, promoting hESC differentiation.
• The PBD-mediated method offers a promising strategy for bone regeneration applications.